$ARDX @ArdelyxMedical @ardelyx IPO price $14. IPO return: down 73%. Current price $3.83. 17 years under Raab. Big Fail. IBSRELA guidance cut, CMS fight lost, CCO walked, stock near 52-week lows. Crown jewel Xphozah twilight zoned. Keep the California talent where the pharma ecosystem is. But relocate HQ to Texas, kill the tax drag, and replace Raab. Chairman David Mott has the MedImmune exit and NEA track record to lead it. The board owes shareholders a fiscal and ethical duty. Enough.
View on X ↗